Answers are grounded in this paper and cite their sources.
This protocol details a prospective randomized placebo-controlled double blind clinical trial to evaluate the safety and efficacy of CLBS03 (autologous ex vivo expanded polyclonal CD4+CD25+CD127lo/-FOXP3+ regulatory T-cells [Tregs]) in adolescents with recent onset Type 1 Diabetes Mellitus.
No takes yet. Share an insight, caveat, or question.
Gitelman et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: